Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05840263
Other study ID # 22-2246.cc
Secondary ID K08CA267313
Status Recruiting
Phase
First received
Last updated
Start date May 31, 2023
Est. completion date December 2025

Study information

Verified date August 2023
Source University of Colorado, Denver
Contact Joshua Pasek
Phone 3037242419
Email joshua.pasek@cuanschutz.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The overall objective of this study is to develop a novel couple-based mindfulness intervention aimed at reducing distress in patients with metastatic colorectal cancer (mCRC) and their partners.


Description:

The overall objective of this study is to develop a novel couple-based mindfulness intervention aimed at reducing distress in patients with metastatic colorectal cancer (mCRC) and their partners. The intervention is named "MIND-Together" (Mindfully Navigating Distress Together). MIND-Together will be the first mindfulness-based intervention designed to reduce mCRC couples' distress by targeting their unique psychosocial needs. The intervention is projected to be a 4-session intervention delivered by a trained therapist to individual couples facing mCRC (i.e., a patient and his/her intimate partner) via video-conference (e.g., Zoom).


Recruitment information / eligibility

Status Recruiting
Enrollment 48
Est. completion date December 2025
Est. primary completion date December 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 85 Years
Eligibility Patient Inclusion Criteria: - Provision to sign and date the consent form. - Stated willingness to comply with all study procedures and be available for the duration of the study. - Be aged > 18 years. - Fluent in English language - Be a person (i.e., patient) diagnosed with metastatic colorectal cancer (mCRC), a partner (e.g., spouse) of someone diagnosed with mCRC, or a clinician who treats patients diagnosed with mCRC. Additional patient participant inclusion criteria: - Has a current diagnosis of metastatic (Stage IV, recurrent) colorectal cancer - Has an ECOG status <2 or otherwise deemed appropriate for study participation by a clinician - Is in a committed relationship with a romantic partner for >6 months - Has access to computer/internet through with video-conferencing (phone, laptop, tablet, desktop computer) - Indicates a score >0 on the Distress Thermometer Additional partner participant inclusion criteria: - Has been in a committed relationship >6 months with a patient who meets the above eligibility criteria - Has access to computer/internet through with video-conferencing (phone, laptop, tablet, desktop computer) - Indicates a score >0 on the Distress Thermometer Additional clinician participant inclusion criteria: ·Is a physician or advanced practice clinician (e.g., oncologist, nurse practitioner, physician assistant, psychologist, mental health provider, etc.) Exclusion Criteria: ·Has a serious mental illness (e.g., psychotic disorder), cognitive impairment (e.g., dementia), or medical condition (e.g., significant impaired sight/hearing) that would compromise participation

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Qualitative interview
Qualitative interviews will cover four main goals including: (1) key sources of distress in mCRC patients and partners; (2) perceptions of mindfulness, including benefits, definitions, and applications; (3) barriers and facilitators of participation (e.g. home-based and couple-based skills practice, enrollment); and (4) session format preferences, such as session length and frequency.
Cognitive Interviews
The objective of the cognitive interviews (60 minutes, led by the PI) is to ensure the comprehensibility and appropriateness of the drafted participant materials. Published guidelines note a sample size of 12 participants (6 mCRC couples) should be sufficient. Participants will be asked to read, review, and mark up the participant materials in order to identify sections that were difficult to understand. They will also be asked to test playing segments of the audio/video recordings to ensure ease of use. A semi-structured interview format will be used to elicit feedback, including a standard verbal survey assessing ease of reading the material, any difficulties experienced, and suggestions they have for improving the ease of material use. Information generated will be used to update materials as necessary.

Locations

Country Name City State
United States University of Colorado Cancer Center Aurora Colorado

Sponsors (2)

Lead Sponsor Collaborator
University of Colorado, Denver National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

References & Publications (34)

Al Daken LI, Ahmad MM. The implementation of mindfulness-based interventions and educational interventions to support family caregivers of patients with cancer: A systematic review. Perspect Psychiatr Care. 2018 Jul;54(3):441-452. doi: 10.1111/ppc.12286. Epub 2018 May 10. — View Citation

Andreu Y, Martinez P, Soto-Rubio A, Fernandez S, Bosch C, Cervantes A. Colorectal cancer survival: prevalence of psychosocial distress and unmet supportive care needs. Support Care Cancer. 2022 Feb;30(2):1483-1491. doi: 10.1007/s00520-021-06513-1. Epub 2021 Sep 16. — View Citation

Birnie K, Garland SN, Carlson LE. Psychological benefits for cancer patients and their partners participating in mindfulness-based stress reduction (MBSR). Psychooncology. 2010 Sep;19(9):1004-9. doi: 10.1002/pon.1651. — View Citation

Cotrim H, Pereira G. Impact of colorectal cancer on patient and family: implications for care. Eur J Oncol Nurs. 2008 Jul;12(3):217-26. doi: 10.1016/j.ejon.2007.11.005. — View Citation

Drury A, Payne S, Brady AM. Cancer survivorship: Advancing the concept in the context of colorectal cancer. Eur J Oncol Nurs. 2017 Aug;29:135-147. doi: 10.1016/j.ejon.2017.06.006. Epub 2017 Jul 10. — View Citation

Drury A, Payne S, Brady AM. Prevalence vs impact: a mixed methods study of survivorship issues in colorectal cancer. Qual Life Res. 2022 Apr;31(4):1117-1134. doi: 10.1007/s11136-021-02975-2. Epub 2021 Aug 21. — View Citation

Graca Pereira M, Figueiredo AP, Fincham FD. Anxiety, depression, traumatic stress and quality of life in colorectal cancer after different treatments: A study with Portuguese patients and their partners. Eur J Oncol Nurs. 2012 Jul;16(3):227-32. doi: 10.1016/j.ejon.2011.06.006. Epub 2011 Jul 23. — View Citation

Han CJ, Yang GS, Syrjala K. Symptom Experiences in Colorectal Cancer Survivors After Cancer Treatments: A Systematic Review and Meta-analysis. Cancer Nurs. 2020 May/Jun;43(3):E132-E158. doi: 10.1097/NCC.0000000000000785. — View Citation

Houldin AD. A qualitative study of caregivers' experiences with newly diagnosed advanced colorectal cancer. Oncol Nurs Forum. 2007 Mar;34(2):323-30. doi: 10.1188/07.ONF.323-330. — View Citation

Kayser K, Acquati C, Reese JB, Mark K, Wittmann D, Karam E. A systematic review of dyadic studies examining relationship quality in couples facing colorectal cancer together. Psychooncology. 2018 Jan;27(1):13-21. doi: 10.1002/pon.4339. Epub 2017 Jan 26. — View Citation

Kotronoulas G, Papadopoulou C, Burns-Cunningham K, Simpson M, Maguire R. A systematic review of the supportive care needs of people living with and beyond cancer of the colon and/or rectum. Eur J Oncol Nurs. 2017 Aug;29:60-70. doi: 10.1016/j.ejon.2017.05.004. Epub 2017 May 30. — View Citation

Langbaum T, Smith TJ. Time to Study Metastatic-Cancer Survivorship. N Engl J Med. 2019 Apr 4;380(14):1300-1302. doi: 10.1056/NEJMp1901103. No abstract available. — View Citation

McGeechan GJ, Byrnes K, Campbell M, Carthy N, Eberhardt J, Paton W, Swainston K, Giles EL. A systematic review and qualitative synthesis of the experience of living with colorectal cancer as a chronic illness. Psychol Health. 2022 Mar;37(3):350-374. doi: 10.1080/08870446.2020.1867137. Epub 2021 Jan 26. — View Citation

Miniotti M, Bassino S, Fanchini L, Ritorto G, Leombruni P. Supportive care needs, quality of life and psychological morbidity of advanced colorectal cancer patients. Eur J Oncol Nurs. 2019 Dec;43:101668. doi: 10.1016/j.ejon.2019.09.009. Epub 2019 Sep 30. — View Citation

Mosher CE, Adams RN, Helft PR, O'Neil BH, Shahda S, Rattray NA, Champion VL. Family caregiving challenges in advanced colorectal cancer: patient and caregiver perspectives. Support Care Cancer. 2016 May;24(5):2017-2024. doi: 10.1007/s00520-015-2995-z. Epub 2015 Nov 4. — View Citation

Musial F, Bussing A, Heusser P, Choi KE, Ostermann T. Mindfulness-based stress reduction for integrative cancer care: a summary of evidence. Forsch Komplementmed. 2011;18(4):192-202. doi: 10.1159/000330714. Epub 2011 Aug 8. — View Citation

Ngamkham S, Holden JE, Smith EL. A Systematic Review: Mindfulness Intervention for Cancer-Related Pain. Asia Pac J Oncol Nurs. 2019 Apr-Jun;6(2):161-169. doi: 10.4103/apjon.apjon_67_18. — View Citation

Northouse LL, Mood D, Templin T, Mellon S, George T. Couples' patterns of adjustment to colon cancer. Soc Sci Med. 2000 Jan;50(2):271-84. doi: 10.1016/s0277-9536(99)00281-6. — View Citation

Peng YN, Huang ML, Kao CH. Prevalence of Depression and Anxiety in Colorectal Cancer Patients: A Literature Review. Int J Environ Res Public Health. 2019 Jan 31;16(3):411. doi: 10.3390/ijerph16030411. — View Citation

Phipps E, Braitman LE, Stites S, Leighton JC. Quality of life and symptom attribution in long-term colon cancer survivors. J Eval Clin Pract. 2008 Apr;14(2):254-8. doi: 10.1111/j.1365-2753.2007.00842.x. Epub 2008 Feb 18. — View Citation

Piet J, Wurtzen H, Zachariae R. The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: a systematic review and meta-analysis. J Consult Clin Psychol. 2012 Dec;80(6):1007-20. doi: 10.1037/a0028329. Epub 2012 May 7. — View Citation

Ramsey SD, Andersen MR, Etzioni R, Moinpour C, Peacock S, Potosky A, Urban N. Quality of life in survivors of colorectal carcinoma. Cancer. 2000 Mar 15;88(6):1294-303. — View Citation

Reese JB, Handorf E, Haythornthwaite JA. Sexual quality of life, body image distress, and psychosocial outcomes in colorectal cancer: a longitudinal study. Support Care Cancer. 2018 Oct;26(10):3431-3440. doi: 10.1007/s00520-018-4204-3. Epub 2018 Apr 20. — View Citation

Rutherford C, Muller F, Faiz N, King MT, White K. Patient-reported outcomes and experiences from the perspective of colorectal cancer survivors: meta-synthesis of qualitative studies. J Patient Rep Outcomes. 2020 Apr 25;4(1):27. doi: 10.1186/s41687-020-00195-9. — View Citation

Sakamoto N, Takiguchi S, Komatsu H, Okuyama T, Nakaguchi T, Kubota Y, Ito Y, Sugano K, Wada M, Akechi T. Supportive care needs and psychological distress and/or quality of life in ambulatory advanced colorectal cancer patients receiving chemotherapy: a cross-sectional study. Jpn J Clin Oncol. 2017 Dec 1;47(12):1157-1161. doi: 10.1093/jjco/hyx152. — View Citation

Schneider EC, Malin JL, Kahn KL, Ko CY, Adams J, Epstein AM. Surviving colorectal cancer : patient-reported symptoms 4 years after diagnosis. Cancer. 2007 Nov 1;110(9):2075-82. doi: 10.1002/cncr.23021. — View Citation

Schneider S, Moyer A, Knapp-Oliver S, Sohl S, Cannella D, Targhetta V. Pre-intervention distress moderates the efficacy of psychosocial treatment for cancer patients: a meta-analysis. J Behav Med. 2010 Feb;33(1):1-14. doi: 10.1007/s10865-009-9227-2. Epub 2009 Sep 27. — View Citation

Schuurhuizen CSEW, Braamse AMJ, Beekman ATF, Cuijpers P, van der Linden MHM, Hoogendoorn AW, Berkhof H, Sommeijer DW, Lustig V, Vrijaldenhoven S, Bloemendal HJ, van Groeningen CJ, van Zweeden AA, van der Vorst MJDL, Rietbroek R, Tromp-van Driel CS, Wymenga MNW, van der Linden PW, Beeker A, Polee MB, Batman E, Los M, van Bochove A, Brakenhoff JAC, Konings IRHM, Verheul HMW, Dekker J. Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized Trial. J Natl Compr Canc Netw. 2019 Aug 1;17(8):911-920. doi: 10.6004/jnccn.2019.7285. — View Citation

Sprangers MA, Taal BG, Aaronson NK, te Velde A. Quality of life in colorectal cancer. Stoma vs. nonstoma patients. Dis Colon Rectum. 1995 Apr;38(4):361-9. doi: 10.1007/BF02054222. — View Citation

Thompson T, Ketcher D, Gray TF, Kent EE. The Dyadic Cancer Outcomes Framework: A general framework of the effects of cancer on patients and informal caregivers. Soc Sci Med. 2021 Oct;287:114357. doi: 10.1016/j.socscimed.2021.114357. Epub 2021 Aug 30. — View Citation

Traa MJ, Braeken J, De Vries J, Roukema JA, Orsini RG, Den Oudsten BL. Evaluating quality of life and response shift from a couple-based perspective: a study among patients with colorectal cancer and their partners. Qual Life Res. 2015 Jun;24(6):1431-41. doi: 10.1007/s11136-014-0872-8. Epub 2014 Nov 28. — View Citation

van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007 Sep;18(9):1437-49. doi: 10.1093/annonc/mdm056. Epub 2007 Mar 12. — View Citation

White N, Newman E. Shared recovery: Couples' experiences after treatment for colorectal cancer. Eur J Oncol Nurs. 2016 Apr;21:223-31. doi: 10.1016/j.ejon.2015.10.008. Epub 2015 Nov 28. — View Citation

Wieldraaijer T, Duineveld LA, van Asselt KM, van Geloven AA, Bemelman WA, van Weert HC, Wind J; ICARE study group. Follow-up of colon cancer patients; causes of distress and need for supportive care: Results from the ICARE Cohort Study. Eur J Surg Oncol. 2017 Jan;43(1):118-125. doi: 10.1016/j.ejso.2016.08.011. Epub 2016 Aug 31. — View Citation

* Note: There are 34 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Identify the needs of mCRC patients for intervention content Completed through semi-structured qualitative interviews During the one-time qualitative interview
Primary Identify the preferences of mCRC patients for intervention content Completed through semi-structured qualitative interviews During the one-time qualitative interview
Primary Identify the needs of mCRC patients' partners for intervention content Completed through semi-structured qualitative interviews During the one-time qualitative interview
Primary Identify the preferences of mCRC patients' partners for intervention content Completed through semi-structured qualitative interviews During the one-time qualitative interview
Primary Identify the preferences of mCRC patients for intervention format (eg, session length) Completed through semi-structured qualitative interviews During the one-time qualitative interview
Primary Identify the preferences of mCRC patients' partners for intervention format (eg, session length) Completed through semi-structured qualitative interviews During the one-time qualitative interview
Primary Identify the preferences of mCRC patients partners for intervention format Completed through semi-structured qualitative interviews During the one-time qualitative interview
Primary Extract key themes to integrate into preliminary drafts analyze these qualitative data to extract key themes and will integrate the findings with preliminary drafts of the MIND-Together protocol (e.g., participant handouts, therapist manual). During the one-time qualitative interview
See also
  Status Clinical Trial Phase
Completed NCT01228734 - A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type Patients Phase 3
Completed NCT05178745 - A Prospective Observational Cohort Study Evaluating Resection Rate in Patients With Metastatic Colorectal Cancer Treated With Aflibercept in Combination With FOLFIRI - Observatoire résection
Completed NCT01591421 - P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer. Phase 1/Phase 2
Withdrawn NCT05412706 - Niraparib Maintenance Treatment in mCRC With a Partial o Complete Response After Oxaliplatin-based Induction Therapy Phase 2
Withdrawn NCT04430985 - FOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal Cancer Phase 2
Withdrawn NCT03182894 - Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer Phase 1/Phase 2
Recruiting NCT05725200 - Study to Investigate Outcome of Individualized Treatment in Patients With Metastatic Colorectal Cancer Phase 2
Terminated NCT03176264 - PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer Phase 1
Completed NCT04866290 - HepaSphere™ Microspheres Prospective Registry
Not yet recruiting NCT06425133 - Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers Phase 2
Not yet recruiting NCT05531045 - 18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic Adenocarcinoma
Withdrawn NCT03982173 - Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors Phase 2
Completed NCT02906059 - Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer Phase 1
Active, not recruiting NCT02575378 - Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal Cancer Phase 4
Withdrawn NCT02535988 - Abscopal Effect for Metastatic Colorectal Cancer Phase 2
Recruiting NCT02848807 - Chemotherapy-related Toxicity, Nutritional Status and Quality of Life N/A
Active, not recruiting NCT02077868 - Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment Phase 3
Completed NCT02414009 - Study to Compare CAPTEM vs FOLFIRI as Second Line Treatment in Advanced, Colorectal Cancer Patients Phase 2
Active, not recruiting NCT01949194 - Study to Determine the Efficacy of Regorafenib in Metastatic Colorectal Cancer Patients and to Discover Biomarkers Phase 2
Withdrawn NCT01915472 - A Phase II Study of IMMU 130 in Patients With Metastatic Colorectal Cancer Phase 2